Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

40.79

-1.56 (-3.68%)

At close: Feb 27, 2026, 4:00 PM EST

41.11

+0.32 (0.78%)

After-hours: Feb 27, 2026, 7:22 PM EST

Vera Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-152.15	-95.99	-89.06	-32.61
Depreciation & Amortization	0.11	0.02	-0.85	0.18
Loss (Gain) From Sale of Assets	-	-	-	-2.69
Asset Writedown & Restructuring Costs	-	-	-	-1
Loss (Gain) From Sale of Investments	-8.97	-4.43	0.81	0.89
Stock-Based Compensation	20.8	11.49	8.89	3.01
Other Operating Activities	2.87	2.55	5.86	5
Change in Accounts Payable	-3.45	-0.87	10.61	0.48
Change in Other Net Operating Assets	6.11	-4.95	-3.86	3.04
Operating Cash Flow	-134.68	-92.18	-67.6	-23.71
Capital Expenditures	-0.97	-0.06	-0.06	-
Sale of Property, Plant & Equipment	-	-	-	0.8
Sale (Purchase) of Intangibles	-	-	-	-5
Investment in Securities	-424.06	-39.37	-70.49	-
Investing Cash Flow	-425.03	-39.43	-70.55	-4.2
Long-Term Debt Issued	-	24.74	19.82	4.92
Total Debt Issued	-	24.74	19.82	4.92
Net Debt Issued (Repaid)	-	24.74	19.82	4.92
Issuance of Common Stock	645.91	116.06	88.21	51.73
Repurchase of Common Stock	-0.01	-	-	-
Other Financing Activities	-39.23	-7.26	-6.1	-2.77
Financing Cash Flow	606.67	133.54	101.93	53.88
Net Cash Flow	46.97	1.93	-36.22	25.97
Free Cash Flow	-135.65	-92.24	-67.66	-23.71
Free Cash Flow Per Share	-2.45	-2.16	-2.55	-1.76
Cash Interest Paid	6.65	3.35	0.9	0.02
Levered Free Cash Flow	-84.35	-58.02	-42.37	-20.38
Unlevered Free Cash Flow	-79.58	-55.66	-41.75	-20.37
Change in Working Capital	2.66	-5.82	6.75	3.51

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q